Abstract
Primary liver tumors and liver metastases are the two most common malignant liver tumors. In cases of unresectable malignant tumors, local ablative therapies are considered as the preferred option. These include transarterial chemoembolization, radioembolization, radiofrequency ablation, microwave ablation, percutaneous alcohol injection, cryotherapy and laser therapy. Local ablative therapies have the additive advantage of preserving the uninvolved liver parenchyma, and can be used in combination or as adjuvant to surgery or bridge to liver transplantation. MRI is more sensitive and accurate compared to CT in detecting and characterize malignant liver lesions pre- and post-therapy. The aim of this article is to describe the MRI appearance of post-treatment liver changes after a wide variety of local ablative therapies and discuss some of the new advances in post-treatment liver imaging.
Keywords: Alcohol ablation, locoregional treatment, malignant liver lesions, microwave ablation, MRI, radiofrequency ablation, transarterial chemoembolization, 90Y radioembolization.
Current Cancer Therapy Reviews
Title:Post-locoregional Therapy MRI Evaluation of Malignant Liver Lesions
Volume: 9 Issue: 3
Author(s): Ilaria Santagostino, Mamdoh AlObaidy, Miguel Ramalho, Kyung Sook Shin, Kiran K.R. Busireddy and Richard C. Semelka
Affiliation:
Keywords: Alcohol ablation, locoregional treatment, malignant liver lesions, microwave ablation, MRI, radiofrequency ablation, transarterial chemoembolization, 90Y radioembolization.
Abstract: Primary liver tumors and liver metastases are the two most common malignant liver tumors. In cases of unresectable malignant tumors, local ablative therapies are considered as the preferred option. These include transarterial chemoembolization, radioembolization, radiofrequency ablation, microwave ablation, percutaneous alcohol injection, cryotherapy and laser therapy. Local ablative therapies have the additive advantage of preserving the uninvolved liver parenchyma, and can be used in combination or as adjuvant to surgery or bridge to liver transplantation. MRI is more sensitive and accurate compared to CT in detecting and characterize malignant liver lesions pre- and post-therapy. The aim of this article is to describe the MRI appearance of post-treatment liver changes after a wide variety of local ablative therapies and discuss some of the new advances in post-treatment liver imaging.
Export Options
About this article
Cite this article as:
Santagostino Ilaria, AlObaidy Mamdoh, Ramalho Miguel, Shin Sook Kyung, Busireddy K.R. Kiran and Semelka C. Richard, Post-locoregional Therapy MRI Evaluation of Malignant Liver Lesions, Current Cancer Therapy Reviews 2013; 9 (3) . https://dx.doi.org/10.2174/157339470903140220145116
DOI https://dx.doi.org/10.2174/157339470903140220145116 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Potential Effect of Anti-Tumour Necrosis Factor-Alpha Treatment on Reducing the Cardiovascular Risk Related to Rheumatoid Arthritis
Current Vascular Pharmacology Pathophysiology of Coronary Collaterals
Current Cardiology Reviews Antidiabetic Effect of Spearmint in Streptozotocin-Induced Diabetic Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets Glaucoma Eye Drops Adverse Skin Reactions
Recent Patents on Inflammation & Allergy Drug Discovery Arterial Hyperoxia in Severe Head Injury: A Useful or Harmful Option?
Current Pharmaceutical Design Clinical Application of PET Myocardial Perfusion Imaging
Current Medical Imaging Recent Advances in Developing Ophthalmic Formulations: A Patent Review
Recent Patents on Drug Delivery & Formulation Human Anthrax as a Re-Emerging Disease
Recent Patents on Anti-Infective Drug Discovery Herbal Oils for Treatment of Chronic and Diabetic Wounds: A Systematic Review
Current Diabetes Reviews Markers of Atherosclerotic Disease: What do they Mean? Current Opinion and Future Trends
Current Pharmaceutical Design Third and Fourth Generation Fluoroquinolone Antibacterials: A Systematic Review of Safety and Toxicity Profiles
Current Drug Safety Nimodipine Reappraised: An Old Drug With a Future
Current Neuropharmacology The Impact of Asymmetric Dimethylarginine (ADAMA), the Endogenous Nitric Oxide (NO) Synthase Inhibitor, to the Pathogenesis of Gastric Mucosal Damage
Current Pharmaceutical Design Endothelial Function and Pathogenesis of Endothelial Dysfunction
Current Immunology Reviews (Discontinued) Implication for Thiazolidinediones (TZDs) as Novel Potential Anti- Inflammatory Drugs
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Lifestyle Factors and Endothelial Function
Current Vascular Pharmacology Development and Optimization of Controlled Release Bioerodable Anti Infective Ophthalmic Insert
Current Drug Delivery Clinical Implications of COX-1 and / or COX-2 Inhibition for the Distal Gastrointestinal Tract
Current Pharmaceutical Design Regulation of Multidrug Resistance by Pro-Inflammatory Cytokines
Current Cancer Drug Targets Adiponectin - A Novel Anti-Atherogenic Factor in the Metabolic Syndrome: Mechanisms of Action and Therapeutic Potential
Vascular Disease Prevention (Discontinued)